Furthermore, recent research has highlighted the possible involvement of PHLDB2 in cancer cell mobility and the process of the epithelial–mesenchymal transition (EMT), which ultimately leads to metastatic progression [20,21]. This evidence concerns the gene PHLDB2 and cancer.